Pharmagest Interactive Sa Stock Net Income
| PHF Stock | EUR 34.85 17.92 33.96% |
As of the 18th of February 2026, Pharmagest Interactive holds the Variance of 17.47, coefficient of variation of (812.40), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmagest Interactive, as well as the relationship between them. Please check Pharmagest Interactive standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha to decide if Pharmagest Interactive is priced some-what accurately, providing market reflects its current price of 34.85 per share.
Pharmagest Interactive Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 523.8 M | Enterprise Value Revenue 5.2485 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 56.2 M | 37.5 M | |
| Net Income Applicable To Common Shares | 53.3 M | 33.6 M | |
| Net Income | 41.6 M | 36.3 M |
Pharmagest | Net Income |
The Net Income trend for Pharmagest Interactive SA offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmagest Interactive is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pharmagest Interactive's Net Income Growth Pattern
Below is the plot of the Net Income of Pharmagest Interactive SA over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Pharmagest Interactive financial statement analysis. It represents the amount of money remaining after all of Pharmagest Interactive SA operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Pharmagest Interactive's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmagest Interactive's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 36.2 M | 10 Years Trend |
|
Net Income |
| Timeline |
Pharmagest Net Income Regression Statistics
| Arithmetic Mean | 30,659,123 | |
| Geometric Mean | 28,739,399 | |
| Coefficient Of Variation | 38.54 | |
| Mean Deviation | 10,076,733 | |
| Median | 25,432,000 | |
| Standard Deviation | 11,817,369 | |
| Sample Variance | 139.7T | |
| Range | 33.5M | |
| R-Value | 0.87 | |
| Mean Square Error | 35.6T | |
| R-Squared | 0.76 | |
| Slope | 2,041,249 | |
| Total Sum of Squares | 2234.4T |
Pharmagest Net Income History
Pharmagest Interactive 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmagest Interactive's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmagest Interactive.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Pharmagest Interactive on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Pharmagest Interactive SA or generate 0.0% return on investment in Pharmagest Interactive over 90 days. Pharmagest Interactive is related to or competes with Zegona Communications, Southwest Airlines, AEGEAN AIRLINES, Charter Communications, CITIC Telecom, and Citic Telecom. Pharmagest Interactive SA provides various IT solutions for the healthcare sector in Europe More
Pharmagest Interactive Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmagest Interactive's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmagest Interactive SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) |
Pharmagest Interactive Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmagest Interactive's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmagest Interactive's standard deviation. In reality, there are many statistical measures that can use Pharmagest Interactive historical prices to predict the future Pharmagest Interactive's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | 52.45 |
Pharmagest Interactive February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 52.46 | |||
| Mean Deviation | 1.01 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.47 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | 52.45 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Pharmagest Interactive Backtested Returns
Pharmagest Interactive maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Pharmagest Interactive exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pharmagest Interactive's Coefficient Of Variation of (812.40), risk adjusted performance of (0.09), and Variance of 17.47 to confirm the risk estimate we provide. The company holds a Beta of -0.01, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pharmagest Interactive are expected to decrease at a much lower rate. During the bear market, Pharmagest Interactive is likely to outperform the market. At this point, Pharmagest Interactive has a negative expected return of -0.58%. Please make sure to check Pharmagest Interactive's standard deviation, information ratio, and the relationship between the coefficient of variation and variance , to decide if Pharmagest Interactive performance from the past will be repeated at some point in the near future.
Auto-correlation | 1.00 |
Perfect predictability
Pharmagest Interactive SA has perfect predictability. Overlapping area represents the amount of predictability between Pharmagest Interactive time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmagest Interactive price movement. The serial correlation of 1.0 indicates that 100.0% of current Pharmagest Interactive price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pharmagest Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Pharmagest Interactive SA reported net income of 36.2 M. This is 89.39% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The net income for all Germany stocks is 93.66% higher than that of the company.
Pharmagest Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmagest Interactive's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharmagest Interactive could also be used in its relative valuation, which is a method of valuing Pharmagest Interactive by comparing valuation metrics of similar companies.Pharmagest Interactive is currently under evaluation in net income category among its peers.
Pharmagest Fundamentals
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0704 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 548.11 M | ||||
| Shares Outstanding | 15.03 M | ||||
| Shares Owned By Insiders | 66.84 % | ||||
| Shares Owned By Institutions | 11.97 % | ||||
| Price To Earning | 53.56 X | ||||
| Price To Book | 8.09 X | ||||
| Price To Sales | 2.33 X | ||||
| Revenue | 219.79 M | ||||
| Gross Profit | 63.96 M | ||||
| EBITDA | 43.42 M | ||||
| Net Income | 36.2 M | ||||
| Cash And Equivalents | 63.28 M | ||||
| Cash Per Share | 4.20 X | ||||
| Total Debt | 19.01 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.36 X | ||||
| Book Value Per Share | 15.30 X | ||||
| Cash Flow From Operations | 57.72 M | ||||
| Earnings Per Share | 1.60 X | ||||
| Number Of Employees | 1.4 K | ||||
| Beta | 0.86 | ||||
| Market Capitalization | 523.84 M | ||||
| Total Asset | 394.05 M | ||||
| Retained Earnings | 47.05 M | ||||
| Working Capital | 24.12 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 394.05 M | ||||
| Last Dividend Paid | 1.25 |
About Pharmagest Interactive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmagest Interactive SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmagest Interactive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmagest Interactive SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Pharmagest Stock
Pharmagest Interactive financial ratios help investors to determine whether Pharmagest Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagest with respect to the benefits of owning Pharmagest Interactive security.